NEW YORK, April 18, 2026 (GLOBE NEWSWIRE) -- AriseAlpha announced the official launch of its AI stock trading bot, expanding its automated investing ecosystem as demand for AI-driven trading tools continues to grow in 2026. The release is designed to provide investors with a more efficient and simplified way to participate in financial markets, particularly…
Tallmadge, OH, April 18, 2026 (GLOBE NEWSWIRE) -- Empower Health Labs MemoShield Memory Support Formula for Brain Boosting Health Benefits is a topic currently gaining attention as consumer interest in memory support supplements continues to expand in 2026. Empower Health Labs has presented MemoShield as part of its broader discussion around cognitive wellness, ingredient research,…
CALGARY, April 18, 2026 (GLOBE NEWSWIRE) -- Every vehicle manufactured carries a unique identifier assigned at production. That identifier follows the vehicle across every owner, every service visit, and every resale - creating a continuous record that informs diagnostics, protects warranties, and supports informed decision-making across decades. The built environment has never had an equivalent.…
Baltimore, MD, April 18, 2026 (GLOBE NEWSWIRE) -- Former CIA advisor and macro economist Jim Rickards has released a new video presentation examining what he describes as a significant and underappreciated divergence in the current market landscape — between the volatility dominating technology and artificial intelligence stocks, and a quieter but data-supported story unfolding in…
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study Paris, April 18, 2026. Sanofi's protein-based non-mRNA COVID-19 vaccine Nuvaxovid (NVX-CoV2705) demonstrated statistically significant lower systemic reactogenicity (the expected side effects that might occur following vaccination) compared to mNEXSPIKE (mRNA-1283), Moderna's latest mRNA COVID-19 vaccine, across all pre-specified endpoints in the COMPARE…
